Intensified processing has become significantly more prevalent in the biopharmaceutical industry over the past few years. By lowering production cost of goods and increasing flexibility in plant ...

Considering this knowledge of the retina, the investigators conducted a study in which the goals were to detect and quantify ...

The perfusion bioreactors market is booming due to rising biopharmaceutical demand, innovations in bioreactor design, and regulatory support. Key opportunities include smaller-scale systems for R&D ...

In a recent review, Trent Munro, PhD, National Biologics Facility, University of Queensland, Australia, writes that “Improvements in process and cell line development, the advent of single-use ...

The demand for producing therapeutic recombinant proteins is generating a renewed interest in perfusion cell culture technologies, leading to the development of cell culture media that can support ...

Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry today announced the launch of the ambr ® 250 high throughput (ht) perfusion, a new automated ...

Read full article: Navigating HPV vaccine hesitancy: A doctor debunks myths, encourages cancer prevention Dr. Kyle Miletic, surgeon, talks about the procedure with heart transplant recipient Ken ...

Achieving high cell densities in long-term cultures is often a challenge facing bioprocessing manufacturers, and one that requires the support of optimal media. FUJIFILM Irvine Scientific recently sat ...

PHILADELPHIA--(BUSINESS WIRE)--VintaBio, a biotech manufacturing technology company specializing in high-yield, high-purity viral vector production for reliable gene therapy access, will present ...

SELARSDI is approved for both adult and pediatric indications and is the second biosimilar approved under the strategic partnership between Alvotech and Teva SELARSDI is expected to be marketed in the ...